xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.authorArtikkelit"Fagard RH"

Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertnsion

Staessen JA; Thijs L; O'Brien ET; Bulpitt CJ; De Leeuw PW; Fagard RH; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Safar ME; SYST-EUR Trial Investigators
AM J HYPERTENS (2002)

Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension

Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; De Leeuw PW; Efstratopoulus AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y; SYST-EUR Trial Investigators; Sarti C
Hypertension (1998)

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-up Study (SYST-EUR 2)

Thijs L; Staessen JA; Beleva S; Birkenhäger WH; Bulpitt CJ; Celis H; Fletcher AE; Kermova R; Leonetti G; Laks T; Mantov S; Nachev C; Sarti C; Tuomilehto J; Fagard RH; Systolic Hypertension in Europe Investigators
Current Controlled Trials in Cardiovascular Medicine : 6 (2001)

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial

Celis H; Thijs L; Staessen JA; Birkenhäger WH; Bulpitt CJ; De Leeuw PW; Leonetti G; Nachev C; Tuomilehto J; Fagard RH; Syst-Eur Investigators
J Hum Hypertens (2001)

On-treatment Diastolic blood pressure and prognosis in systolic hypertension

Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
Arch Intern Med (2007)

Predictive value of clinic and ambulatory heart rate for mortality in elderly subject with systolic hypertension

Palatini P; Thijs L; Staessen JA; Fagard RH; Bulpitt CJ; Clement DL; de Leeuw PW; Jääskivi M; Leonetti G; Nachev C; O'Brien ET; Parati G; Rodicio JL; Roman E; Sarti C; Tuomilehto J
Arch Intern Med (2002)

Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension

Fagard RH; Staessen JA; Thijs L; Celis H; Birkenhäge WH; Bulpitt CJ; De Leeuw PW; Leonetti G; Sarti C; Tuomilehto J; Webster J; Yodfat Y; Systolic Hypertension in Europe (Syst-Eur) Trial Investigato
Hypertension (2004)

Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension

Fagard RH; Staessen JA; Thijs L; Bulpitt CJ; Clement D; de Leeuw PW; Jääskivi M; Mancia g; O'Brien E; Palatini P; Tuomilehto J; Webster J; Systolic Hypertension in Europe Trial Investigators
J Hypertens (2004)

Systolic blood pressure variablilty as a risk factor for stroke adn cardiovascular mortality in the elderly hypertensive population

Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; De Leeuw PW; Jaaskivi M; Nachev C; Parati G; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH
J Hypertens (2003)

Systolic hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress

Gasowski J; Staessen JA; Celis H; Fagard RH; Thijs L; Birkenhäger WH; Bulpitt CJ; Fletcher AE; Arabidze GG; De Leeuw P; Dollery CT; Duggan J; Kawecka-Jaszcz K; Leonetti G; Nachev C; Safar M; Rodico JL; Rosenfeld J; Seux ML; Tuomilehto J; Webster J; Yodfat Y; on behalf of Syst-Eur Investigators; Sarti C
J Hum Hypertens (1999)

Withdrawal from treatment in the SYST-EUR Trial

Bulpitt CJ; Beckett NS; Fletcher AE; Thijs l; Staessen JA; Dumitrascu DL; Forette F; Leonetti G; Nachev C; Tuomilehto J; Fagard RH
J Hypertens : 2 (2002)

Artikkelit - Selaus tekijän mukaan "Fagard RH"

Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertnsion ﻿

Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension ﻿

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-up Study (SYST-EUR 2) ﻿

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial ﻿

On-treatment Diastolic blood pressure and prognosis in systolic hypertension ﻿

Predictive value of clinic and ambulatory heart rate for mortality in elderly subject with systolic hypertension ﻿

Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension ﻿

Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension ﻿

Systolic blood pressure variablilty as a risk factor for stroke adn cardiovascular mortality in the elderly hypertensive population ﻿

Systolic hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress ﻿

Withdrawal from treatment in the SYST-EUR Trial ﻿